Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
ChinaCache International Holdings Ltd. (NASDAQ: CCIH) shares surged 17.41 percent to close at $17.87 a share Tuesday. The stock traded between $15.44 and $18.45 on volume of 1.45 million shares traded. The company announced a strategic partnership with Server Farm Realty, LLC related to ChinaCache’s Atecsys International Data Center. Shares of ChinaCache are up approximately 100.0 percent year-to-date.
Get more information on ChinaCache and free access to the in-depth equity report at: www.FiveStarEquities.com/CCIH
Cumulus Media Inc. (NASDAQ: CMLS) shares jumped 8.75 percent to close at $7.33 a share Tuesday. The stock traded between $6.73 and $7.43 on volume of 2.32 million shares traded. The company reported net revenues were $275.5 million for the fourth quarter of 2013, an increase of $11.9 million when compared to a year ago. Shares of Cumulus Media are down approximately 5.0 percent year-to-date.
Get more information on Cumulus Media and free access to the in-depth equity report at: www.FiveStarEquities.com/CMLS
Lightbridge Corp. (NASDAQ: LTBR) shares soared 24.24 percent to close at $2.87 a share Tuesday. The stock traded between $2.50 and $3.28 on volume 2.10 million shares traded. The company announced that the U.S. Patents and Trademarks Office have approved its patent for its multi-lobed metallic fuel rod design and fuel assemblies. Shares of Lightbridge are up approximately 98.0 percent year-to-date.
Get more information on Lightbridge and free access to the in-depth equity report at: www.FiveStarEquities.com/LTBR
Myriad Genetics, Inc. (NASDAQ: MYGN) shares spiked 11.42 percent to close at $35.03 a share Tuesday. The stock traded between $31.44 and $35.36 on volume 5.10 million shares traded. The company announced that it has published positive Prolaris data in the Journal of Urology. Shares of Myriad Genetics are up approximately 65.0 percent year-to-date.
Get more information on Myriad Genetics free access to the in-depth equity report at: www.FiveStarEquities.com/MYGN
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]